What's in IRCCS San Raffaele's pipeline?

IRCCS San Raffaele has 15 drugs in our index: 3 marketed, 0 filed, 3 in Phase 3, 6 in Phase 2, 3 in Phase 1.

Which companies overlap with IRCCS San Raffaele's portfolio?

Top competitors by shared drug class: National Taiwan University Hospital, Addpharma Inc., Beijing Minhai Biotechnology Co., Ltd, Amsterdam UMC, location VUmc, Baqiyatallah Medical Sciences University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/irccs-san-raffaele.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

IRCCS San Raffaele — Portfolio Competitive Intelligence Brief

IRCCS San Raffaele pipeline: 3 marketed, 0 filed, 3 Phase 3, 6 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 3 Phase 3 6 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Insulin glargine plus insulin analogues	Insulin glargine plus insulin analogues	marketed
"Drug:Carvedilol" and "Drug:Ivabradine"	"Drug:Carvedilol" and "Drug:Ivabradine"	marketed
Antiarrhythmic Drug Therapy	Antiarrhythmic Drug Therapy	marketed
NUCS	NUCS	phase 3	SARS-CoV-2 main protease inhibitor	SARS-CoV-2 main protease	Infectious Diseases
PEG-IFNa 2a	PEG-IFNa 2a	phase 3	Interferon	IFNAR	Oncology
Atazanavir/ritonavir monotherapy	Atazanavir/ritonavir monotherapy	phase 3	HIV protease inhibitor	HIV protease	Infectious Disease

Therapeutic area mix

Oncology · 3
Infectious Disease · 1
Infectious Diseases · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

National Taiwan University Hospital · 2 shared drug classes
Addpharma Inc. · 1 shared drug class
Beijing Minhai Biotechnology Co., Ltd · 1 shared drug class
Amsterdam UMC, location VUmc · 1 shared drug class
Baqiyatallah Medical Sciences University · 1 shared drug class
Bayer · 1 shared drug class
Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
Active Biotech AB · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for IRCCS San Raffaele:

Cite this brief

Drug Landscape (2026). IRCCS San Raffaele — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/irccs-san-raffaele. Accessed 2026-05-16.